BIO R&D Expenses

Bio-Rad Laboratories, Inc. Class A Common Stock · R&D Expenses

BIO logo

BIO R&D Expenses

Latest reported$261.10M
BIO R&D Expenses ($0.00 → $261.10M)
High-resolution chart · PNG

BIO r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
256,899,999
295,900,000
247,427,000
256,889,000
260,638,000
217,763,000
202,710,000
199,196,000
250,301,000
205,864,000
192,972,000
220,333,000
210,952,000
214,040,000
186,439,000
172,266,000
163,585,000
159,518,000
140,535,000
123,376,000
115,104,000
108,344,000
94,270,000
82,935,000
76,543,000
68,140,000
51,200,000
41,400,000
46,100,000
39,600,000
34,700,000
30,200,000
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.